Healthcare - Biotechnology - NASDAQ - CH
$ 5.33
0.947 %
$ 223 M
Market Cap
-2.49
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
72.53%
EBIT
Estimate
8.90%
Net Income
Estimate
6.86%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Molecular Partners AG
MOLN has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart MOLN
EBIT FORECAST
EBIT Forecast Chart MOLN
NET INCOME FORECAST
Net Income Chart MOLN